Back to Agenda
NEW TRENDS IN INVITRO NON-CLINICAL TESTING
Session Chair(s)
Sonja Beken, PhD, MSc
Chair 3Rs Working Party, EMA; Coordinator Non Clinical Evaluators
Federal Agency for Medicines and Health Products, Belgium
This session will provide an overview of the new and emerging trends in in vitro non-clinical testing. On one hand the recent advances in regulatory acceptance of in vitro testing paradigms will be highlighted. On the other, industry experience will be given on the use of 3D cell cultures and of induced pluripotent stem cells in predictive toxicology and on the use of the MIMIC system for in vitro assessment of immunogenicity.
Speaker(s)
Update on Acceptance of in vitro Testing Paradigms
Sonja Beken, PhD, MSc
Federal Agency for Medicines and Health Products, Belgium
Chair 3Rs Working Party, EMA; Coordinator Non Clinical Evaluators
Stephane Dhalluin
UCB Pharma SA, Belgium
Director, Investigative Non-Clinical Safety
Biomimetic in vitro Models: Getting human responses in a “test tube”
William Warren, PhD
Sanofi Pasteur Vax Design, United States
Vice President
Have an account?